Article
Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age
19 Jan 2018
Abstract excerpt
BACKGROUND: The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women (improved maternal health and prevention of mother to child transmission [pMTCT]) currently outweigh the adverse effects due to cART. As the variety of cART increases, however, the question arises as to which type of cART is safest for pregnant women and women of childbearing age. We studied the effect of timing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
